| Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells MM Lederman, L Calabrese, NT Funderburg, B Clagett, K Medvik, ... Journal of Infectious Diseases 204 (8), 1217-1226, 2011 | 356 | 2011 |
| Rheumatic immune-related adverse events of checkpoint therapy for cancer: case series of a new nosological entity C Calabrese, E Kirchner, A Kontzias, V Velcheti, LH Calabrese RMD open 3 (1), e000412, 2017 | 191 | 2017 |
| Rheumatic complications of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: emergence of a new syndrome of immune reconstitution and … LH Calabrese, E Kirchner, R Shrestha Seminars in arthritis and rheumatism 35 (3), 166-174, 2005 | 181 | 2005 |
| Polymyalgia rheumatica-like syndrome from checkpoint inhibitor therapy: case series and systematic review of the literature C Calabrese, LC Cappelli, M Kostine, E Kirchner, T Braaten, L Calabrese RMD open 5 (1), e000906, 2019 | 69 | 2019 |
| Heart transplantation in patients with eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) M Groh, G Masciocco, E Kirchner, A Kristen, C Pellegrini, S Varnous, ... The Journal of Heart and Lung Transplantation 33 (8), 842-850, 2014 | 48 | 2014 |
| The frequency of low muscle mass and its overlap with low bone mineral density and lipodystrophy in individuals with HIV—a pilot study using DXA total body composition analysis B Buehring, E Kirchner, Z Sun, L Calabrese Journal of Clinical Densitometry 15 (2), 224-232, 2012 | 43 | 2012 |
| Early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in patients with immune-mediated inflammatory disease undergoing B cell depleting therapy and those with … C Calabrese, E Kirchner, A Villa-Forte, RA Hajj-Ali, BP Moss, ... RMD open 8 (2), e002557, 2022 | 28 | 2022 |
| The 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis should include new standards for hepatitis B screening: comment on the article by … LH Calabrese, C Calabrese, E Kirchner Arthritis care & research 68 (5), 723-724, 2016 | 27 | 2016 |
| Breakthrough SARS–CoV‐2 Infections in Patients With Immune‐Mediated Disease Undergoing B Cell–Depleting Therapy: A Retrospective Cohort Analysis CM Calabrese, E Kirchner, EM Husni, BP Moss, AP Fernandez, Y Jin, ... Arthritis & Rheumatology 74 (12), 1906-1915, 2022 | 25 | 2022 |
| Safety of recombinant zoster vaccine: a retrospective study of 622 rheumatology patients T Lenfant, Y Jin, E Kirchner, RA Hajj-Ali, LH Calabrese, C Calabrese Rheumatology 60 (11), 5149-5157, 2021 | 25 | 2021 |
| Long COVID and rheumatology: Clinical, diagnostic, and therapeutic implications C Calabrese, E Kirchner, LH Calabrese Best Practice & Research Clinical Rheumatology 36 (4), 101794, 2022 | 21 | 2022 |
| Myalgia and arthralgia immune-related adverse events (irAEs) in patients with genitourinary malignancies treated with immune checkpoint inhibitors MC Ornstein, C Calabrese, LS Wood, E Kirchner, P Profusek, KD Allman, ... Clinical Genitourinary Cancer 17 (3), 177-182, 2019 | 12 | 2019 |
| Cryoglobulinemic vasculitis and lymphocytic interstitial pneumonitis in a person with HIV infection. JR Castillo, E Kirchner, C Farver, LH Calabrese The AIDS Reader 15 (5), 252-255, 2005 | 10 | 2005 |
| Commentaries on Viewpoint: muscle atrophy is not always sarcopenia SSS SARCOPENIA people 17, 349-359, 2012 | 8 | 2012 |
| Infections in the era of targeted therapies: mapping the road ahead LH Calabrese, C Calabrese, T Lenfant, E Kirchner, V Strand Frontiers in Medicine 7, 336, 2020 | 6 | 2020 |
| Breakthrough SARS-CoV-2 infections in immune mediated disease patients undergoing B cell depleting therapy CM Calabrese, E Kirchner, EM Husni, BP Moss, AJ Fernandez, Y Jin, ... medRxiv, 2022.02. 21.22271289, 2022 | 3 | 2022 |
| The Evolving Role of the Rheumatology Practitioner in the Care of Immunocompromised Patients in the COVID‐19 Era LH Calabrese, CM Calabrese, E Kirchner, K Winthrop Arthritis & Rheumatology (Hoboken, Nj) 74 (12), 1868, 2022 | 2 | 2022 |
| Rheumatoid Arthritis: Pathophysiology and Safe Administration of Biologics E Kirchner Journal of Infusion Nursing 40 (6), 364-366, 2017 | 2 | 2017 |
| Rheumatic Immune Related Adverse Events from Checkpoint Inhibitor Therapy for Cancer: Long-Term Follow up Data C Calabrese, E Kirchner, A Kontzias, L Wood, B Rini, V Velcheti, ... ARTHRITIS & RHEUMATOLOGY 69, 2017 | 2 | 2017 |
| Barriers to immunizations and strategies to enhance immunization rates in adults with autoimmune inflammatory diseases E Kirchner, V Ruffing Rheumatic Disease Clinics 43 (1), 15-26, 2017 | 2 | 2017 |
